Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20261102003Phase 1Recruiting
Phase 1, open-label trial of propofol, lidocaine and fentanyl in None (2 arms), sponsored by Hue University of Medicine and Pharmacy. Primary endpoint: Adequate sedation rate. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20261102003.